> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Approves Bracco Barium-based Contrast Agent
- URL: https://www.fdaweb.com/fda-approves-bracco-barium-based-contrast-agent/
- Published: 2016-02-02T12:00:00.000Z
- Updated: 2026-09-15T02:32:23.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5134648

> FDA has approved a Bracco Diagnostics NDA for E-Z-HD, a barium-based contrast agent for use in double-contrast radiographic examinations of the esophagus, stomach, and duodenum to visualize the gastrointestinal tract in patients 12 years and older. This is the first regulatory approval of a barium-based contrast agent in the U.S., according to the company. E-Z-HD is the first in a series of new drug approvals that Bracco is pursuing for its entire line of barium sulfate contrast agents, it says. The product is manufactured for Bracco Diagnostics by E-Z-EM Canada Inc.